Search

everythinglearnresearchcommunity

for

Search:↓

PRP and cell therapies may help with hair loss, but more research is needed.

Tofacitinib improves nail conditions in patients with severe hair loss and does not affect hair regrowth.

Nonsteroid treatments for alopecia areata show promise but need more high-quality research.

The PRP-like cosmetic with biomimetic peptides is potentially effective and safe for treating alopecia areata.

Hair loss from alopecia areata and androgenetic alopecia can be treated, but more effective and safer treatments are needed.

Fractional lasers and microneedling, combined with topical agents, could potentially treat Alopecia Areata effectively, but more research is needed due to limited data.

Combining mometasone furoate cream with adapalene gel is safer and more effective for hair regrowth in alopecia areata than using the cream alone.

A woman had a rare skin condition with recurring painful nodules that heal in 6 weeks, often without needing treatment.

Beard hair loss can signal early diabetes and thyroid issues, treatable with specific cream.

Up to 50% of scalp hair can be lost before it appears thin, and treatment is only needed for hair loss caused by diseases or deficiencies.

Various treatments exist for alopecia areata, but none are completely satisfactory; choice depends on age, disease extent, and preference.

New treatments for skin diseases are more effective and patient-friendly, but many still lack a cure.

Skin reactions are a common reason for emergency visits due to drug allergies, with some severe cases needing intensive care.

Dermatologists' treatment of alopecia areata is inconsistent, especially for children and advanced stages.

Tofacitinib may be safe for COVID-19 patients with alopecia without worsening symptoms, based on two cases.

Cancer treatments can cause skin-related side effects that may affect patient quality of life and require changes in treatment.

A patient with a severe type of hair loss experienced partial hair regrowth after treatment with a specific light therapy and a medication called interferon α2a.

Albendazole can cause hair loss, and piroxicam can cause fixed drug eruption.

Traditional treatment for pediatric alopecia areata is most effective and should be first choice.

New cytokine-targeted therapies show promise for treating alopecia areata.

Many treatments for hair loss show potential, but more testing is needed to confirm their effectiveness. Only minoxidil for women and minoxidil and finasteride for men are FDA approved.

Treating alopecia areata is difficult due to limited approved treatments, but new therapies like JAK inhibitors show promise.

Tofacitinib and adalimumab are promising treatments for cicatricial alopecia with few side effects.

PRP can reduce pain and improve function, but more standardized research is needed.

A young child with complete hair loss improved significantly with a combination of hair growth treatments and laser therapy.

PRP may help hair growth in alopecia areata without major side effects, but more research is needed.

Getting insurance to cover the hair loss treatment tofacitinib is hard because it's not officially approved for that use.

Platelet-Rich Plasma (PRP) therapy can effectively treat various hair loss conditions, improve hair count, thickness, and density, and potentially speed up results when combined with surgical techniques.

Enhancing melanin's energy generation may help treat alopecia areata.

Modern hair restoration techniques can effectively treat hair loss and provide natural-looking results.